QC
ASND icon

Quantedge Capital’s Ascendis Pharma A/S ASND Stock Holding History

Quantedge Capital’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.52M Buy
11,000
+1,800
+20% +$404K 1.38% 16
2025
Q4 		$1.96M Buy
9,200
+2,100
+30% +$434K 0.93% 24
2025
Q3 		$1.41M Buy
+7,100
New +$1.32M 0.77% 26

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Quantedge Capital's ASND Position: Q1 2026 in Review

Quantedge Capital increased its Ascendis Pharma A/S (ASND) stake by 20% in Q1 2026, buying an estimated $404K and bringing the position to 11,000 shares worth $2.52M. The position accounts for 1.38% of the portfolio, ranked #16.

Quantedge Capital first reported a position in ASND in Q3 2025 and has held it in 3 quarters since. 273 funds tracked by Wall St. Rank hold ASND as of Q1 2026.

  • Quantedge Capital held 11,000 shares of Ascendis Pharma A/S worth $2.52M as of Q1 2026.
  • Quantedge Capital bought 1,800 Ascendis Pharma A/S shares in Q1 2026, an estimated $404K.
  • Ascendis Pharma A/S made up 1.38% of Quantedge Capital's portfolio in Q1 2026, its #16 holding.
  • Quantedge Capital first reported a position in Ascendis Pharma A/S in Q3 2025 and has held it in 3 quarters since.
  • 273 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q1 2026.

Based on Quantedge Capital's 13F filing for Q1 2026, filed 12 May 2026.